WuXi pushes investors into frenzy with IPO

John Loh

June 08, 2017 12:00 pm

Thumbs up_230px — Group of caucasian white people making hand Thumbs up sign isolated on white background. Like, approval or endorsment concept. | Igor Stevanovic/igor - Fotolia

Investors went crazy for WuXi Biologics’ HK$3.9bn ($500.4m) Hong Kong IPO, driving pricing to the top of expectations as hundreds of global accounts poured in.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs China Merchants Securities Co Equity Bank of America Hong Kong SAR Asia Greater China Morgan Stanley Northeast Asia Asia Pacific Emerging Markets

JL

John Loh